{"goal": [[" We sought to investigate this using 11 C-DASB PET, a marker of SERT binding, and 11 C-raclopride PET, a marker of dopamine D2 receptor availability which is influenced by rises in synaptic dopamine levels after a medication challenge with levodopa.", {"pattern": {"sp_index": 85, "sub": ["We"], "pred": ["sought"], "nes": {"PET": 2, "SERT": 1}, "cds": {"PET": 2}}, "sp": 2, "ne": 16, "cd": 1, "sid": "17", "total": 19, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]], "method": [[" We studied 12 PD patients without LIDs, Received in revised form 19 November 2014 12 PD patients with LIDs, and 12 healthy control subjects.", {"pattern": {"nes": {"Received": 1, "LIDs": 2}, "cds": {"patients": 2, "subjects": 1, "November": 1}}, "sp": 0, "ne": 2, "cd": 152, "sid": "1", "total": 154, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], ["We recruited 24 nondemented and nondepressed PD patients from UK university hospital movement disorder clinics who ful- filled the UK Brain Bank criteria for PD ( Hughes et al., 1992).", {"pattern": {"sp_index": 16, "sub": ["We"], "pred": ["recruited"], "nes": {"Hughes": 1, "UK": 1}, "cds": {"patients": 1}}, "sp": 5, "ne": 1, "cd": 126, "sid": "18", "total": 132, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]], "findings": [[" We found normal levels of GPi SERT binding in PD patients with LIDs, which were 23%e29% raised compared with PD patients with a stable response to levodopa.", {"pattern": {"sp_index": 3, "sub": ["We"], "pred": ["found"], "nes": {"GPi": 1, "LIDs": 1}, "cds": {"%": 1}}, "sp": 9, "ne": 8, "cd": 0, "sid": "63", "total": 17, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], [" Because it has been suggested that exogenous dopamine can be converted and stored in serotonergic terminals, and be released as a false neurotransmitter (Carta et al., 2010; Lindgren et al., 2010), we studied GP D2 receptor availability and indirectly dopamine release with a double 11 C-raclopride PET experiment.", {"pattern": {"sp_index": 100, "sub": ["we"], "pred": ["studied"], "nes": {"PET": 1, "Carta": 1, "GP D2": 1}, "cds": {"experiment": 1}}, "sp": 2, "ne": 16, "cd": 0, "sid": "69", "total": 18, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]]}